Carisma Therapeutics INC. (CARM) — 8-K Filings

All 8-K filings from Carisma Therapeutics INC.. Browse 26 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (26)

8-K Filing — Dec 5, 2025
Carisma Therapeutics Files 8-K on Officer/Director Changes — Oct 15, 2025 Risk: medium
Carisma Therapeutics Inc. filed an 8-K on October 15, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of c
Carisma Therapeutics Faces Delisting Notice — Oct 9, 2025 Risk: high
Carisma Therapeutics Inc. filed an 8-K on October 9, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, formerly
Carisma Therapeutics Terminates Material Definitive Agreement — Sep 18, 2025 Risk: medium
Carisma Therapeutics Inc. announced on September 16, 2025, the termination of a material definitive agreement. The company, formerly known as Sesen Bio, Inc. an
Carisma Therapeutics Reports Material Agreements & Control Changes — Aug 29, 2025 Risk: medium
Carisma Therapeutics Inc. filed an 8-K on August 29, 2025, reporting several key events. These include entering into a material definitive agreement, unregister
Carisma Therapeutics Files 8-K on Shareholder Vote Matters — Aug 8, 2025 Risk: low
Carisma Therapeutics Inc. filed an 8-K on August 8, 2025, reporting on a submission of matters to a vote of security holders that occurred on August 5, 2025. Th
Carisma Therapeutics Faces Delisting Concerns — Jul 15, 2025 Risk: high
Carisma Therapeutics Inc. filed an 8-K on July 15, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The earliest event repo
Carisma Therapeutics Inc. Files 8-K: Material Agreement — Jun 23, 2025 Risk: medium
On June 22, 2025, Carisma Therapeutics Inc. entered into a material definitive agreement. The filing also includes Regulation FD disclosures and financial state
Carisma Therapeutics Files 8-K — Jun 12, 2025 Risk: low
Carisma Therapeutics Inc. filed an 8-K on June 12, 2025, reporting an event that occurred on June 10, 2025. The filing is categorized under 'Other Events' and p
Carisma Therapeutics Faces Delisting Notice — Apr 16, 2025 Risk: high
Carisma Therapeutics Inc. filed an 8-K on April 16, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company's stock wa
Carisma Therapeutics Inc. Files 8-K, Details Name Changes — Jan 13, 2025 Risk: low
On January 13, 2025, Carisma Therapeutics Inc. filed an 8-K report. The filing indicates a change in the company's former name from Sesen Bio, Inc. on May 16, 2
Carisma Therapeutics Faces Delisting Notice — Jan 10, 2025 Risk: high
Carisma Therapeutics Inc. filed an 8-K on January 10, 2025, reporting a notice of delisting or failure to meet continued listing standards as of January 6, 2025
Carisma Therapeutics Files 8-K: Board, Officer, and Compensation Updates — Dec 26, 2024 Risk: low
Carisma Therapeutics Inc. filed an 8-K on December 26, 2024, reporting changes related to its board of directors and officers, as well as compensatory arrangeme
Carisma Therapeutics to be Acquired by 03 Life Sciences — Dec 9, 2024 Risk: medium
Carisma Therapeutics Inc. announced on December 7, 2024, that it has entered into a definitive agreement to be acquired by 03 Life Sciences. The transaction is
Carisma Therapeutics Files 8-K on Financials — Nov 7, 2024 Risk: low
Carisma Therapeutics Inc. filed an 8-K on November 7, 2024, reporting on its results of operations and financial condition. The filing includes financial statem
Carisma Therapeutics Appoints New CMO and Board Member — Oct 30, 2024 Risk: medium
Carisma Therapeutics Inc. announced on October 24, 2024, the appointment of Dr. Steven D. F. R. Kelly as Chief Medical Officer and Dr. David M. Epstein as a new
Carisma Therapeutics Faces Nasdaq Delisting Warning — Oct 11, 2024 Risk: high
Carisma Therapeutics Inc. announced on October 10, 2024, that it received a notice from the Nasdaq Stock Market indicating a failure to meet continued listing r
Carisma Therapeutics Files 8-K on Financials — Aug 8, 2024 Risk: low
Carisma Therapeutics Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing also includes financial sta
Carisma Therapeutics Files 8-K — Jul 9, 2024 Risk: low
Carisma Therapeutics Inc. filed an 8-K on July 9, 2024, reporting other events and financial statements. The company, formerly known as Sesen Bio, Inc. and Elev
Carisma Therapeutics Reports Exit Costs — Jul 2, 2024 Risk: medium
Carisma Therapeutics Inc. filed an 8-K on July 2, 2024, reporting costs associated with exit or disposal activities as of June 26, 2024. The filing details the
Carisma Therapeutics Announces Board Changes — Jul 1, 2024 Risk: low
Carisma Therapeutics Inc. announced on June 26, 2024, the departure of Dr. Steven T. Rosen, a director, and the election of Dr. Jonathan R. Lurie as a new direc
Carisma Therapeutics Files 8-K: Other Events & Financials — Jun 27, 2024 Risk: medium
On June 27, 2024, Carisma Therapeutics Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicatin
Carisma Therapeutics Appoints Dr. Steven T. Rosen to Board — Jun 14, 2024 Risk: medium
Carisma Therapeutics Inc. announced on June 13, 2024, the appointment of Dr. Steven T. Rosen as a new member of its Board of Directors. Dr. Rosen brings extensi
Carisma Therapeutics Files 8-K on Financials — May 9, 2024 Risk: low
Carisma Therapeutics Inc. filed an 8-K on May 9, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhib
Carisma Therapeutics Files 8-K — Apr 10, 2024 Risk: low
Carisma Therapeutics Inc. filed an 8-K on April 10, 2024, reporting other events and financial statements. The company, formerly known as Sesen Bio, Inc. and El
Carisma Therapeutics Files 8-K on Operations — Apr 1, 2024 Risk: low
Carisma Therapeutics Inc. filed an 8-K on April 1, 2024, reporting on its results of operations and financial condition. The filing also includes financial stat

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX